Načítá se...
Rituximab Treatment in Myasthaenia Gravis: Report of two paediatric cases
Myasthaenia gravis (MG) is an auto-immune disease involving the postsynaptic receptors in the neuromuscular junction. The condition is characterised by fatigable weakness of the skeletal muscles and is uncommon in children. Acetylcholinesterase inhibitors and immune-modifying medications are usually...
Uloženo v:
| Vydáno v: | Sultan Qaboos Univ Med J |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Sultan Qaboos University Medical Journal, College of Medicine & Health Sciences
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6132519/ https://ncbi.nlm.nih.gov/pubmed/30210856 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18295/squmj.2018.18.02.018 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|